Search

Your search keyword '"M. M. Asaad"' showing total 70 results

Search Constraints

Start Over You searched for: Author "M. M. Asaad" Remove constraint Author: "M. M. Asaad"
70 results on '"M. M. Asaad"'

Search Results

1. Renal and Depressor Activities of Inhibitors of Neutral Endopeptidase and Angiotensin Converting Enzyme in Monkeys Infused with Angiotensin II

2. A role for endothelin ETa receptors in regulation of renal function in spontaneously hypertensive rats

Catalog

Books, media, physical & digital resources

3. Synthesis of benzo-fused, 7,5- and 7,6-fused azepinones as conformationally restricted dipeptide mimetics

4. POTENTIATION OF NATRIURETIC PEPTIDES BY NEUTRAL ENDOPEPTIDASE INHIBITORS

5. SODIUM LOADS ENHANCE THE NATRIURETIC RESPONSES TO ATRIAL NATRIURETIC PEPTIDE AND NEUTRAL ENDOPEPTIDASE INHIBITORS IN CONSCIOUS CYNOMOLGUS MONKEYS

6. Dual metalloprotease inhibitors. IV. Utilization of thiazepines and thiazines as constrained peptidomimetic surrogates in mercaptoacyl dipeptides

7. Dual metalloprotease inhibitors. III. utilization of bicyclic and monocyclic diazepinone based mercaptoacetyls

8. Dual metalloprotease inhibitors. II. Effect of substitution and stereochemistry on benzazepinone based mercaptoacetyls

9. Mercaptoacyl dipeptides as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Preliminary structure-activity studies

10. Dual metalloprotease inhibitors. I. constrained peptidomimetics of mercaptoacyl dipeptides

11. Effects of the Endothelin (ET) Receptor Antagonist BQ 123 on Initial and Delayed Vascular Responses Induced by ET-1 in Conscious, Normotensive Rats

12. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure

13. ChemInform Abstract: Mercaptoacyl Dipeptides as Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase. Preliminary Structure-Activity Studies

16. ChemInform Abstract: Dual Metalloprotease Inhibitors. Part 5. Utilization of Bicyclic Azepinonethiazolidines and Azepinonetetrahydrothiazines in Constrained Peptidomimetics of Mercaptoacyl Dipeptides

17. ChemInform Abstract: Dual Metalloprotease Inhibitors. Part 6. Incorporation of Bicyclic and Substituted Monocyclic Azepinones as Dipeptide Surrogates in Angiotensin-Converting Enzyme (ACE)/Neutral Endopeptidase (NEP) Inhibitors

18. ChemInform Abstract: N-Formyl Hydroxylamine Containing Dipeptides: Generation of a New Class of Vasopeptidase Inhibitors

19. The effects of novel cathepsin E inhibitors on the big endothelin pressor response in conscious rats

20. Evaluation of SQ 28 603, an inhibitor of neutral endopeptidase, in conscious monkeys

21. Heart Failure Augments the Cardiovascular and Renal Effects of Neutral Endopeptidase Inhibition in Rats

22. Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral Endopeptidase

23. Role of atrial natriuretic peptide in sodium balance in conscious spontaneously hypertensive rats

24. N-formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors

25. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril

26. Vasopeptidase inhibitors: incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides

27. Effects of omapatrilat in low, normal, and high renin experimental hypertension

28. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase

29. In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors

30. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors

31. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors

32. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors

33. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure

34. Atrial natriuretic peptide in chronically hypertensive dogs

35. Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs

36. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure

37. Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats

38. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats

39. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors

40. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats

41. Stability of plasma atrial natriuretic peptide after storage

43. Renal abnormalities in mutant mice

44. Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogs of bestatin

45. L-Thyroxine and monoamine oxidase activity in the kidney and some other organs of the rat

46. Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril

47. ChemInform Abstract: Substituted 1,2,3,4-Tetrahydroaminonaphthols: Antihypertensive Agents, Calcium Channel Blockers, and Adrenergic Receptor Blockers with Catecholamine-Depleting Effects

49. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives

50. Perinephritis hypertension in Macaca fascicularis (cynomolgus monkey)